Pricing
Login
Home
Charts
Search
Watchlist
Products

Acutaas Chemicals Ltd

ACUTAAS
₹3,833.50-3.61%20 Nov 2026
Reports
Pharma CRAMS

Acutaas Chemicals Ltd

ACUTAAS
₹3,833.50
-3.61%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹31,385Cr
Close
Close Price
₹3,833.50
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
71.47
PS
Price To Sales
19.71
Revenue
Revenue
₹1,593Cr
Rev Gr TTM
Revenue Growth TTM
45.18%
PAT Gr TTM
PAT Growth TTM
95.78%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
166225177247275308207306393433330437
Growth YoY
Revenue Growth YoY%
9.220.714.943.165.237.117.324.143.040.359.142.7
Expenses
ExpensesCr
140182147198206224156211243249217261
Operating Profit
Operating ProfitCr
2743304969855195151184113176
OPM
OPM%
15.919.216.719.825.027.524.631.138.342.434.340.3
Other Income
Other IncomeCr
311826161051125
Interest Expense
Interest ExpenseCr
324111111111
Depreciation
DepreciationCr
4567678810101013
PBT
PBTCr
2437205063835896145184104167
Tax
TaxCr
6125121820142438502944
PAT
PATCr
182615384563447210613475123
Growth YoY
PAT Growth YoY%
-20.1-5.6-34.0320.7155.2144.2199.691.3133.7114.170.471.4
NPM
NPM%
10.711.48.315.216.520.321.223.527.031.022.828.2
EPS
EPS₹
2.43.41.84.75.73.95.48.813.216.19.115.3
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
166225177247275308207306393433330437
Growth YoY
Revenue Growth YoY%
9.220.714.943.165.237.117.324.143.040.359.142.7
Expenses
ExpensesCr
140182147198206224156211243249217261
Operating Profit
Operating ProfitCr
2743304969855195151184113176
OPM
OPM%
15.919.216.719.825.027.524.631.138.342.434.340.3
Other Income
Other IncomeCr
311826161051125
Interest Expense
Interest ExpenseCr
324111111111
Depreciation
DepreciationCr
4567678810101013
PBT
PBTCr
2437205063835896145184104167
Tax
TaxCr
6125121820142438502944
PAT
PATCr
182615384563447210613475123
Growth YoY
PAT Growth YoY%
-20.1-5.6-34.0320.7155.2144.2199.691.3133.7114.170.471.4
NPM
NPM%
10.711.48.315.216.520.321.223.527.031.022.828.2
EPS
EPS₹
2.43.41.84.75.73.95.48.813.216.19.115.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1541601882392403415206177171,0071,3391,593
Growth
Revenue Growth%
4.317.426.70.542.152.718.616.340.333.045.2
Expenses
ExpensesCr
136137158196199260415494589775859969
Operating Profit
Operating ProfitCr
182331424180105123128232480623
OPM
OPM%
11.814.416.217.617.123.520.219.917.923.135.939.1
Other Income
Other IncomeCr
30303134-25174223
Interest Expense
Interest ExpenseCr
333566626634
Depreciation
DepreciationCr
112344101216273642
PBT
PBTCr
1819283535729111282216483600
Tax
TaxCr
57101271820293356126161
PAT
PATCr
131219232754728349160356439
Growth
PAT Growth%
-4.853.525.917.996.633.215.8-41.5229.3122.295.8
NPM
NPM%
8.27.59.89.811.515.813.813.56.815.926.627.5
EPS
EPS₹
7.48.717.110.511.45.89.943.553.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1541601882392403415206177171,0071,3391,593
Growth
Revenue Growth%
4.317.426.70.542.152.718.616.340.333.045.2
Expenses
ExpensesCr
136137158196199260415494589775859969
Operating Profit
Operating ProfitCr
182331424180105123128232480623
OPM
OPM%
11.814.416.217.617.123.520.219.917.923.135.939.1
Other Income
Other IncomeCr
30303134-25174223
Interest Expense
Interest ExpenseCr
333566626634
Depreciation
DepreciationCr
112344101216273642
PBT
PBTCr
1819283535729111282216483600
Tax
TaxCr
57101271820293356126161
PAT
PATCr
131219232754728349160356439
Growth
PAT Growth%
-4.853.525.917.996.633.215.8-41.5229.3122.295.8
NPM
NPM%
8.27.59.89.811.515.813.813.56.815.926.627.5
EPS
EPS₹
7.48.717.110.511.45.89.943.553.6
Sales CAGR
1 Year33%
3 Years29%
5 Years32%
TTM45%
EBITDA CAGR
1 Year107%
3 Years58%
5 Years43%
TTM108%
PAT CAGR
1 Year122%
3 Years62%
5 Years46%
TTM96%
Avg. ROCE
1 Year29%
3 Years18%
5 Years19%
TTM32%
CFO / EBITDA
1 Year61%
3 Years64%
5 Years55%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
111132363637414141
Reserves
ReservesCr
721011354865586371,2691,6131,817
Current Liabilities
Current LiabilitiesCr
10695166129163285202231253
Non Current Liabilities
Non Current LiabilitiesCr
252580710128274247
Total Liabilities
Total LiabilitiesCr
2132324136597671,0961,5491,9842,221
Current Assets
Current AssetsCr
1241212164304574967928811,012
Non Current Assets
Non Current AssetsCr
891111972293106007581,1031,209
Total Assets
Total AssetsCr
2132324136597671,0961,5491,9842,221
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
111132363637414141
Reserves
ReservesCr
721011354865586371,2691,6131,817
Current Liabilities
Current LiabilitiesCr
10695166129163285202231253
Non Current Liabilities
Non Current LiabilitiesCr
252580710128274247
Total Liabilities
Total LiabilitiesCr
2132324136597671,0961,5491,9842,221
Current Assets
Current AssetsCr
1241212164304574967928811,012
Non Current Assets
Non Current AssetsCr
891111972293106007581,1031,209
Total Assets
Total AssetsCr
2132324136597671,0961,5491,9842,221

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
152728-1266125118292
Investing Cash Flow
Investing Cash FlowCr
-21-24-101-121-33-365-224-266
Financing Cash Flow
Financing Cash FlowCr
6072140-122392614
Net Cash Flow
Net Cash FlowCr
03-1820-115630
Free Cash Flow
Free Cash FlowCr
-76-77-46-13-190-76-36
CFO To PAT
CFO To PAT%
63.798.651.8-16.678.7257.073.882.0
CFO To EBITDA
CFO To EBITDA%
35.366.034.9-11.353.597.451.060.8
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
152728-1266125118292
Investing Cash Flow
Investing Cash FlowCr
-21-24-101-121-33-365-224-266
Financing Cash Flow
Financing Cash FlowCr
6072140-122392614
Net Cash Flow
Net Cash FlowCr
03-1820-115630
Free Cash Flow
Free Cash FlowCr
-76-77-46-13-190-76-36
CFO To PAT
CFO To PAT%
63.798.651.8-16.678.7257.073.882.0
CFO To EBITDA
CFO To EBITDA%
35.366.034.9-11.353.597.451.060.8

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,6423,2394,0369,99420,94531,385
Price To Earnings
Price To Earnings
50.638.994.3125.958.871.5
Price To Sales
Price To Sales
7.05.35.69.915.619.7
Price To Book
Price To Book
7.05.56.015.312.716.9
EV To EBITDA
EV To EBITDA
33.726.032.742.043.249.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
28.929.933.833.935.833.038.051.151.1
OPM
OPM%
11.814.416.217.617.123.520.219.917.923.135.939.1
NPM
NPM%
8.27.59.89.811.515.813.813.56.815.926.627.5
ROCE
ROCE%
30.624.425.518.719.29.916.828.832.4
ROE
ROE%
28.324.632.413.814.07.212.321.623.6
ROA
ROA%
10.911.813.110.910.94.410.318.019.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,6423,2394,0369,99420,94531,385
Price To Earnings
Price To Earnings
50.638.994.3125.958.871.5
Price To Sales
Price To Sales
7.05.35.69.915.619.7
Price To Book
Price To Book
7.05.56.015.312.716.9
EV To EBITDA
EV To EBITDA
33.726.032.742.043.249.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
28.929.933.833.935.833.038.051.151.1
OPM
OPM%
11.814.416.217.617.123.520.219.917.923.135.939.1
NPM
NPM%
8.27.59.89.811.515.813.813.56.815.926.627.5
ROCE
ROCE%
30.624.425.518.719.29.916.828.832.4
ROE
ROE%
28.324.632.413.814.07.212.321.623.6
ROA
ROA%
10.911.813.110.910.94.410.318.019.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr53,58938,27931,85931,38526,48318,45518,234
Close PriceClose₹951.051,800.70239.303,833.5020,642.001,609.30451.70
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE87.17101.2271.4758.5297.56
Price To SalesPS26.1916.143.2619.7111.4810.965.18
RevenueRevenueCr2,0462,3719,7791,5932,3071,6843,522
Revenue Growth TTMRev Gr TTM%-1.2%15.5%9.4%45.2%50.5%10.7%-6.0%
PAT Growth TTMPAT Gr TTM%18.9%31.4%-782.0%95.8%88.4%-104.1%-60.3%
Market CapitalizationMkt CapCr53,58938,27931,85931,38526,48318,45518,234
Close PriceClose₹951.051,800.70239.303,833.5020,642.001,609.30451.70
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE87.17101.2271.4758.5297.56
Price To SalesPS26.1916.143.2619.7111.4810.965.18
RevenueRevenueCr2,0462,3719,7791,5932,3071,6843,522
Revenue Growth TTMRev Gr TTM%-1.2%15.5%9.4%45.2%50.5%10.7%-6.0%
PAT Growth TTMPAT Gr TTM%18.9%31.4%-782.0%95.8%88.4%-104.1%-60.3%
Interviews